Key result
Percutaneous transvenous mitral balloon valvotomy in patients with mitral stenosis significantly shortened left atrial activation times from 118 to 82 ms (P<0.05), reversing conduction asymmetry.
Why the study?
Does percutaneous transvenous mitral balloon valvotomy (PTMV) improve left atrial conduction abnormalities in patients with mitral stenosis?
Observational (n=17)
Does percutaneous transvenous mitral balloon valvotomy (PTMV) improve left atrial conduction abnormalities in patients with mitral stenosis?
Percutaneous transvenous mitral balloon valvotomy immediately reverses left atrial conduction delay, dispersion, and asymmetry in patients with mitral stenosis, potentially reducing arrhythmogenesis.
Answers are grounded in this paper and cite their sources.
May support reduced arrhythmogenesis with PTMV in mitral stenosis; leaves open arrhythmia outcomes in prospective studies.
AIMS: Left atrial (LA) stretch-associated electrophysiological changes in patients with mitral stenosis (MS) predispose to atrial fibrillation. We hypothesized that the normalization of the pressure gradient by percutaneous transvenous mitral balloon valvotomy (PTMV) affects LA but not right atrial (RA) conduction, depending on the site of stimulation. Because direction-dependent (asymmetric) changes of conduction may contribute to arrhythmogenesis, we assessed conduction symmetry in MS patients and tested whether it is restored by PTMV. METHODS AND RESULTS: In nine patients with MS, atrial effective refractory period and local activation times (ATs) were determined during stimulation before and after PTMV, with up to four decapolar catheters (LA and RA). Eight patients with ventricular pre-excitation served as controls. ATs at basic cycle length were similar before and after PTMV. With stimulation from either atrium, they were about 45 ms in the ipsilateral atrium and about 115 ms in the contralateral atrium. With premature stimulation, ATs increased dramatically. The shortest ATs were found in the RA with RA stimulation (78 +/- 9 and 80 +/- 6 ns, before and after PTMV). PTMV caused a shortening in LA-ATs (following LA stimulation) from 118 +/- 14 to 82 +/- 5 ms (before and after; P < 0.05). Asymmetry in conduction properties was therefore normalized by PTMV. PTMV led to a decrease in RA-ATs (following LA stimulation) from 196 +/- 11 to 174 +/- 13 ms (P < 0.02). In addition, following RA stimulation, the dispersion in ATs in the LA decreased significantly by PTMV (from 66 +/- 10 to 34 +/- 7 ms; P < 0.02). CONCLUSION: MS is associated with LA conduction delay, increased LA dispersion of conduction, and conduction asymmetry. These changes are immediately reversible by PTMV.
No takes yet. Share an insight, caveat, or question.
Coronel et al. (2009) conducted an observational in Mitral stenosis (n=17). Percutaneous transvenous mitral balloon valvotomy (PTMV) vs. Baseline (before PTMV) was evaluated on Left atrial activation times (LA-ATs) following LA stimulation (p=<0.05). Percutaneous transvenous mitral balloon valvotomy in patients with mitral stenosis significantly shortened left atrial activation times from 118 to 82 ms (P<0.05), reversing conduction asymmetry.
Synapse has enriched 10 related papers. Consider them for comparative context: